Vitamin C IV Therapy in Atlanta
Vitamin C (ascorbic acid) is an essential water-soluble vitamin and antioxidant. Intravenous administration achieves much higher blood levels than oral supplementation.
Vitamin C has a role in immune cell function, antioxidant recycling and collagen formation. Evidence for general wellness benefit from IV vitamin C is limited.

Overview
Vitamin C exists primarily as ascorbic acid (reduced form) and dehydroascorbic acid (oxidized form), with these forms interconverting based on cellular redox conditions. The molecule's structure contains two ionizable hydroxyl groups that donate electrons, enabling its antioxidant function. Humans cannot synthesize vitamin C due to loss of the L-gulonolactone oxidase enzyme, making it an essential dietary nutrient.
At physiological pH, vitamin C exists predominantly as ascorbate anion. The compound's ability to donate electrons while remaining relatively stable makes it an ideal antioxidant and reducing agent. Its water solubility allows rapid distribution throughout aqueous body compartments following IV administration.
.avif)
Chemical structure & Properties
- Molecular Formula: C₆H₈O₆
- Molecular Weight: 176.12 g/mol
- Chemical Name: L-Ascorbic acid
- Chemical Class: Water-soluble vitamin, lactone
- pH: Acidic (approximately 2.1-2.6 in solution)
- Stability: Sensitive to heat, light, and oxygen; requires proper storage
Mechanism of Action
Dose Considerations: Dosing is set by your provider based on your history, screening results and baseline vitamin C status.
Safety Profile and Considerations
Regulatory Status and
Clinical Use
FDA Status
Vitamin C is an approved vitamin and dietary supplement; high-dose IV use for disease treatment represents off-label application
Clinical Use
Used off-label by healthcare providers
Compounding Status
Available through pharmacies and compounding facilities in various concentrations
Quality Considerations:
Pharmaceutical-grade ascorbic acid required; proper pH buffering important for tolerability
High-dose IV vitamin C therapy represents off-label use based on established physiological roles, emerging clinical evidence, decades of clinical experience in integrative medicine, and growing research support.
Clinical Considerations
The Paragon Method: Step-by-Step
Administration and Treatment
- Route: Intravenous infusion over extended period for high doses
- Infusion Rate: Typically 0.5-1.0 g per minute; slower rates improve tolerance
- Duration: 30 minutes to 3+ hours depending on dose (higher doses require longer infusion times)
- Frequency: Set by your provider based on your history, screening and response
- Hydration: Adequate hydration before and after treatment essential

Patient Selection
Appropriate candidates are determined at a clinical evaluation, including a full medication review.

Pre-Treatment Assessment
- Comprehensive medical history including kidney disease and stone history
- G6PD screening when indicated by ethnicity or family history
- Renal function evaluation (creatinine, eGFR)
- Current medications review
- Iron status assessment if concerns for overload
- Baseline symptom and functional status documentation
- Informed consent discussing off-label use and dose-specific considerations

Optimization Strategies
- Adequate hydration 1-2 hours before treatment (16-32 oz water)
- Light meal before high-dose infusions to prevent hypoglycemia
- Calcium and magnesium co-administration may reduce side effects
- Slower infusion rates for first treatment to assess tolerance
- Continued hydration after treatment to support renal excretion
- Regular session schedules based on your goals and provider guidance
- Avoidance of NAD+-depleting substances (excessive alcohol, smoking)

During Infusion Management
- Vital signs monitoring at start and intervals during high-dose infusions
- Patient comfort assessment and communication
- Rate adjustment based on tolerance
- Blood glucose monitoring in diabetic patients during very high doses
- Vein site monitoring for irritation
- Vein site monitoring for irritation

Post-Treatment Care
- Observation period after infusion completion
- Hydration encouragement (16-24 oz water)
- Assessment of immediate response and side effects
- Education about potential temporary fatigue followed by energy increase
- Discussion of what to expect after treatment
- Scheduling of follow-up treatments based on protocol
- Scheduling of follow-up treatments based on protocol

Monitoring
- Session-by-session tolerance assessment
- Progressive evaluation of response and tolerability
- Periodic renal function monitoring with regular high-dose therapy
- Long-term wellness parameter tracking

.avif)
Conclusion
Vitamin C IV therapy delivers vitamin C directly into the bloodstream, after a provider review and safety screening, including G6PD testing.
Evidence for general wellness benefit is limited. Whether it is appropriate for you is a clinical decision made after evaluation.
References
Carr AC, Maggini S. Vitamin C and immune function. Nutrients. 2017;9(11):1211.
Fritz H, et al. Intravenous vitamin C and cancer: A systematic review. Integr Cancer Ther. 2014;13(4):280-300.
Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2013;2013(1):CD000980.
Fowler AA, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure. JAMA. 2019;322(13):1261-1270.
Padayatty SJ, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140(7):533-537.
Levine M, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci USA. 1996;93(7):3704-3709.
Chen Q, et al. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl Acad Sci USA. 2005;102(38):13604-13609.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. While vitamin C is an essential nutrient and approved vitamin, high-dose IV administration for disease treatment represents off-label use not approved by the FDA. Patients should consult with qualified healthcare providers before considering any IV therapy. G6PD screening is essential before high-dose administration. The content reflects current scientific literature and clinical practice as of 2025. Individual results may vary, and treatment appropriateness should be determined on a case-by-case basis by licensed medical professionals. This therapy should only be administered by trained healthcare providers with appropriate screening, monitoring, and emergency preparedness.